Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity. Meng-Ju Wu # </sp … ← CDK6: HSC fate and cell cycle nexus? Phase 2 Trial of the Farnesyltransferase Inhibitor Tipifarnib for Relapsed/Refractory Peripheral T Cell Lymphoma →